Sort
51,593 grants matching “hepatitis”
Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans
$746,545Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2020 · AI
Center for Humanized Mice
$746,325Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2016 · OD
ZCM: A novel broad-spectrum microbicide for STIs
$746,027Melissa J Robbiani · Population Council · U19 · FY2010 · AI
Therapeutic Strategies and Molecular Correlates in Aggressive B-cell Lymphomas
$745,944Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Social, Genomic, and Epigenomic Drivers of Clopidogrel Response in Puerto Ricans
$745,930Minoli A Perera · Northwestern University At Chicago · R01 · FY2024 · HG
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$745,921Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression
$745,882Raymond T Chung · Massachusetts General Hospital · R01 · FY2014 · DK
HEPATITIS C VIRUS PERSISTENCE AND PATHOGENESIS
$745,865University Of Southern California · U19 · FY2003 · AI
HT Image Assay of Lipid Droplet Formation in Human Adipocytes
$745,749Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2009 · DK
Bay Area Hepatitis C Cooperative Research Center
$745,655Joseph M McCune · University Of California, San Francisco · U19 · FY2010 · AI
NanoDisk-Amphotericin B therapy for aspergillosis
$745,652Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2011 · AI
Enhancing immune regulation in gene therapy for hemophilia
$745,554Roland W. Herzog · University Of Florida · R01 · FY2016 · HL
Immune Regulation In Toxoplasmosis And Other Opportunistic Infections
$745,431Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Enhancing immune regulation in gene therapy for hemophilia
$745,423Roland W. Herzog · Indiana University Indianapolis · R01 · FY2025 · HL
Alimentary Tract Lipids in Health and Disease
$745,379Martin Conrad Carey · Brigham And Women'S Hospital · R37 · FY2006 · DK
Exosomal biomarkers for the early detection of hepatocellular carcinoma
$745,286Ajay Goel · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Targeting the gut-liver axis in cardiovascular disease
$745,258Thomas A Vallim · University Of California Los Angeles · R01 · FY2025 · HL
Targeting the gut-liver axis in cardiovascular disease
$745,258Thomas A Vallim · University Of California Los Angeles · R01 · FY2023 · HL
Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance
$745,195Jerrold M Olefsky · University Of California, San Diego · R24 · FY2011 · DK
20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK
$745,178Stephen Sidney · Kaiser Foundation Research Institute · R01 · FY2008 · HL
Advancement of poxvirus inhibitor
$745,122John H Connor · Boston University Medical Campus · R01 · FY2024 · AI
T cell Immunity and the Outcome of Acute HCV Infection
$745,107Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2018 · AI
Therapy of transplantation-induced oxidative injury using polymeric antioxidants
$744,990Michael W Fanger · Celdara Medical, Llc · R44 · FY2015 · DK
Kupffer Cells and HIV-1 Persistence
$744,943Ashwin Balagopal · Johns Hopkins University · R56 · FY2015 · AI
Risk Factors for AIDS Among Intravenous Drug Users
$744,928Beth Israel Medical Ctr (New York) · R01 · FY2005 · DA